Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy
暂无分享,去创建一个
Iulia A. Popescu | S. Piechnik | C. Kramer | M. Salerno | R. Kwong | K. Werys | Qiang Zhang | A. Barutcu | V. Ferreira | H. Watkins | S. Neubauer | M. Jerosch-Herold | E. Lukaschuk | C. Nikolaidou | M. Burrage | M. Shanmuganathan | E. Hann | Rebecca E Mills | Suleyman D Polat
[1] Stefan K. Piechnik,et al. Deep neural network ensemble for on-the-fly quality control-driven segmentation of cardiac MRI T1 mapping , 2021, Medical Image Anal..
[2] Stefan L. Zimmerman,et al. Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials – A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study , 2021, International journal of cardiology.
[3] Matthew W. Martinez,et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.
[4] Konrad Werys,et al. Deep learning with attention supervision for automated motion artefact detection in quality control of cardiac T1-mapping , 2020, Artif. Intell. Medicine.
[5] Iulia A. Popescu,et al. Standardization of T1-mapping in cardiovascular magnetic resonance using clustered structuring for benchmarking normal ranges. , 2020, International journal of cardiology.
[6] V. Ferreira,et al. Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy , 2020, Current Heart Failure Reports.
[7] Víctor M. Campello,et al. Cardiac Segmentation on Late Gadolinium Enhancement MRI: A Benchmark Study from Multi-Sequence Cardiac MR Segmentation Challenge , 2020, Medical Image Anal..
[8] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[9] J. Xu,et al. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction. , 2019, Radiology.
[10] M. Dweck,et al. Myocardial fibrosis: why image, how to image and clinical implications , 2019, Heart.
[11] Víctor M. Campello,et al. Combining Multi-Sequence and Synthetic Images for Improved Segmentation of Late Gadolinium Enhancement Cardiac MRI , 2019, STACOM@MICCAI.
[12] D. Rueckert,et al. Unsupervised Multi-modal Style Transfer for Cardiac MR Segmentation , 2019, STACOM@MICCAI.
[13] S. Solomon,et al. A First in Human Study of the Selective Cardiac Myosin Inhibitor, CK-3773274 , 2019, Journal of Cardiac Failure.
[14] J. Seidman,et al. Novel Therapies for Prevention and Early Treatment of Cardiomyopathies. , 2019, Circulation research.
[15] A. Owens,et al. Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy , 2019, Annals of Internal Medicine.
[16] R. Blankstein,et al. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis , 2019, Journal of Cardiovascular Magnetic Resonance.
[17] J. Cornel,et al. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. , 2018, JACC. Cardiovascular imaging.
[18] J. Pauly,et al. Deep learning enables reduced gadolinium dose for contrast‐enhanced brain MRI , 2018, Journal of magnetic resonance imaging : JMRI.
[19] Philip H. S. Torr,et al. Learn To Pay Attention , 2018, ICLR.
[20] Richard B. Thompson,et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.
[21] S. Piechnik,et al. State-of-the-art review: stress T1 mapping—technical considerations, pitfalls and emerging clinical applications , 2017, Magnetic Resonance Materials in Physics, Biology and Medicine.
[22] Einar Heiberg,et al. Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories , 2017, Journal of Cardiovascular Magnetic Resonance.
[23] K. Sugimura,et al. Radiologic-Pathologic Correlation of Primary and Secondary Cardiomyopathies: MR Imaging and Histopathologic Findings in Hearts from Autopsy and Transplantation. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.
[24] K. Diao,et al. Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis , 2016, Journal of Cardiovascular Magnetic Resonance.
[25] R. Chan,et al. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.
[26] Alexei A. Efros,et al. Image-to-Image Translation with Conditional Adversarial Networks , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[27] Li Fei-Fei,et al. Perceptual Losses for Real-Time Style Transfer and Super-Resolution , 2016, ECCV.
[28] Martín Abadi,et al. TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems , 2016, ArXiv.
[29] Daniel Messroghli,et al. State of the Art: Clinical Applications of Cardiac T1 Mapping. , 2016, Radiology.
[30] N. Geller,et al. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.
[31] Thomas Brox,et al. U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.
[32] Jimmy Ba,et al. Adam: A Method for Stochastic Optimization , 2014, ICLR.
[33] Martin Borggrefe,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.
[34] Martin Rajchl,et al. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy , 2014, Journal of Cardiovascular Magnetic Resonance.
[35] Andrew Zisserman,et al. Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.
[36] Michael S. Bernstein,et al. ImageNet Large Scale Visual Recognition Challenge , 2014, International Journal of Computer Vision.
[37] Stefan Neubauer,et al. T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences , 2013, Magnetic resonance in medicine.
[38] Saurabh Shah,et al. T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: a preliminary study. , 2013, European journal of radiology.
[39] J. Duerk,et al. Magnetic Resonance Fingerprinting , 2013, Nature.
[40] Andrew S Flett,et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.
[41] E. Nagel,et al. European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.
[42] Stefan Neubauer,et al. Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[43] David Vancraeynest,et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. , 2012, Journal of the American College of Cardiology.
[44] Francesca N. Delling,et al. Intermediate-Signal-Intensity Late Gadolinium Enhancement Predicts Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[45] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[46] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[47] E. McVeigh,et al. Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.
[48] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[49] Carsten Rother,et al. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study. , 2019, Investigative radiology.
[50] Yang Yan-zon. Interpretation of guidelines on 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy , 2012 .